Compliance after solid organ transplantation: Influence of quality of life and of the heath-care-provider-patient relationship;Compliance nach organtransplantation - Einfluss von lebensqualität und arzt-patienten-beziehung

Deutsche Medizinische Wochenschrift

Volumn 132, Issue 1-2, 2007, Pages 40-44

  Kugler, Christiane ^a   Fischer, S ^a   Simon, A R ^a   Haverich, A ^a   Struber M ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Compliance; Health care provider patient relationship; Quality of life; Solid organ transplantation

Indexed keywords

HEALTH CARE PERSONNEL; IMMUNOSUPPRESSIVE TREATMENT; ORGAN TRANSPLANTATION; PATIENT ATTITUDE; PATIENT COMPLIANCE; PREVALENCE; QUALITY OF LIFE; REVIEW; DOCTOR PATIENT RELATION; HUMAN; PSYCHOLOGICAL ASPECT;

HUMANS; ORGAN TRANSPLANTATION; PATIENT COMPLIANCE; PHYSICIAN-PATIENT RELATIONS; QUALITY OF LIFE;

EID: 33947140492     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-959287     Document Type: Review

References (38)

1. Bullinger M, Kirchberger I. SF-36 Fragebogen zum Gesundheitszustand. Handanweisung. Hogrefe Verlag Göttingen, 1998
2. Bunzel B, Laederach-Hofmann K. Solid organ transplantation: are there predictors for posttransplant noncompliance? A literature overview. Transplantation 2000; 70: 711-716
3. Burke LE, Ockene IS. Compliance in Healthcare and Research. Monograph Series by the American Heart Association. Futura Publishing Company, Inc. Armonk, 2001
4. Butler J, Mc Coin NS, Feurer ID et al. Modelling the effects of functional performance and post-transplant comorbidities and health-related quality of life after heart transplantation. J Heart Lung Transplant 2003; 22: 1149-1156
5. Chisholm MA. Enhancing transplant patients' adherence to medication therapy. Clin Transplantation 2002; 16: 30-38
6. Cupples SA, Steslow B. Use of behavioral contingency contracting with heart transplant candidates. Progr Transplantation 2001; 11: 137-144
7. De Geest S, Borgersmans L, Gemoets H et al. Incidence, determinants, and consequences of subclinical noncompliance with immunosuppressive therapy in renal transplant recipients. Transplantation 1995; 59: 340-347
8. De Geest S, Abraham I, Moons P et al. Late acute rejection and subclinical noncompliance with cyclosporine therapy in heart transplant recipients. J Heart Lung Transplantation 1998; 17: 854-863
9. De Geest S, Abraham I, Dunbar-Jacob J, Vanhaecke J. Behavioral strategies for long-term survival of transplant recipients. In: Metry JM and Meyer UA, editors. Drug Regimen Compliance: Issues in Trials and Patient Management 1999. John Wiley & Sons Chichester, New York, Weinheim, Brisbane, Singapore, Toronto, 1999: 163-179
10. Dew MA. Behavioral factors in heart transplantation: Quality of life and medical compliance. J Appl Biobehav Res 1994; 2: 28-54
11. Diekmann A. Empirische Sozialforschung. Grundlagen, Methoden, Anwendungen. Rowohlts Verlag Weinheim, 1998: 299-300
12. Dobbels F, Put C, Vanhaecke J. Personality disorders: a challenge for transplantation. Progr Transplantation 2000; 10: 226-232
13. Dobbels F, De Geest S, Van Cleemput J, Droogne W, Vanhaecke J. Effect of late medication non-compliance on outcome after heart transplantation: a 5-year follow-up. J Heart Lung Transplant 2004; 23: 1245-1251
14. Drent G, Haagsma EB, De Geest S et al. Prevalence of prednisolone (non)compliance in adult liver transplant recipients. Transplant International 2005; 18: 960-966
15. Dunbar-Jacob J, Erlen JA, Schlenk EA, Ryan CM, Sereika SM, Doswell WM. Adherence in chronic disease (Chapter 3). Ann Rev Nurs Res 2000; 18: 48-90
16. Feinstein AR. On white-coat effects and the electronic monitoring of compliance. Arch Intern Med 1990; 150: 1377-1378
17. Grady KL, Jalowiec A, White-Williams C. Patient compliance at one year and two years after heart transplantation. J Heart Lung Transplant 1998; 17: 383-394
18. Greenstein S, Siegal B. Compliance and noncompliance in patients with a functioning renal transplant: a multicenter study. Transplantation 1998; 66: 1718-1726
19. Hathaway DK, Winsett R, Prendergast M, Subaiya I. The first report from the patient outcomes registry for transplant effects on life (PORTEL): differences in side-effects and quality of life by organ type, time since transplant and immunosuppressive regimens. Clin Transplantation 2003; 17: 183-194
20. Haynes RB, Taylor DW, Sackett DL. Compliance in Health Care. Johns Hopkins University Press Baltimore and London, 1979: 4-17
21. Haynes RB, Mc Kibbon KA, Kanani R. Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications. Lancet 1996; 348: 383-386
22. Hilbrands LB, Hoitsma AJ, Koene RA. Medication compliance after renal transplantation. Transplantation 1995; 60: 914-920
23. Karam VH, Gasquet I, Delvart V et al. Quality of life in adult survivors beyond 10 years after liver, kidney, and heart transplantation. Transplantation 2003; 76: 1699-1704
24. Kugler C, Fischer S, Gottlieb J et al. Symptom experiences for patients after lung transplantation: influences on adherence and quality of life (Review). Clin Transplantation 2006; in press
25. Kugler C, Fischer S, Gottlieb J et al. Health-related quality of life in two hundred-eighty lung transplant recipients. J Heart Lung Transplantation 2005; 24: 2262-2268
26. Meichenbaum D, Turk DC. Therapiemotivation des Patienten. Verlag Hans Huber Bern, Göttingen, Toronto, Seattle, 1994: 56-75
27. Moons P, De Geest S, Abraham I et al. Symptom experience associated with maintenance immunosuppression after heart transplantation: patients appraisal of side effects. Heart & Lung 1998; 27: 315-325
28. Moons P, De Geest S, Versteven K et al. Psychometric Properties of the "Modified Transplant Symptom Occurrence and Symptom Distress Scale". J Nurs Measurement 2001; 9: 115-134
29. Pascual M, Theruvat T, Kawai T, Tolkoff-Rubin N, Cosimi AB. Strategies to improve long-term outcomes after renal transplantation. N Engl J Med 2002; 346: 580-589
30. Rubin RH. Gastrointestinal infectious disease complications following transplantation and their differentiation from immunosuppressant- induced gastrointestinal toxicities. Clin Transplant 2001(Suppl 415: 11-22
31. Schweizer RT, Rovelli M, Palmeri D, Vossler E, Hull D, Bartus S. Non-compliance in organ transplant recipients. Transplantation 1990; 49: 374-377
32. Shapiro PA, Williams DL, Foray AT et al. Psychosocial evaluation and prediction of compliance problems and morbiditiy after heart transplantation. Transplantation 1995; 60: 1462-1466
33. Siegrist J, Broer M, Junge A. PLC Profil der Lebensqualität chronisch Kranker. Manual. Beltz- Verlag Göttingen, 1996
34. Stilley CS, Dew MA, Pilkonis P et al. Personality characteristics among cardiothoracic transplant recipients. Gen Hosp Psychiatry 2005; 27: 113-118
35. Teichman BJ, Burker EJ, Weiner M et al. Factors associated with adherence to treatment regimens after lung transplantation. Progr Transplantat 2000; 10: 113-121
36. Vlaminck H, Maes B, Evers G et al. Prospective study on late consequences of subclinical non-compliance with immunosuppressive therapy in renal transplant patients. Am J Transplant 2004; 4: 1509-1513
37. Warschburger P. Lebensqualität und Compliance - Die Sichtweise des Patienten. Hogrefe Verlag Göttingen, In Petermann F (Hrsg.). Compliance und Selbstmanagement. 1998: 103-138
38. Winsett RP, Stratta RJ, Alloway R, Wicks MN, Hathaway DK. Immunosuppressant side effect profile does not differ between organ transplant types. Clin Transplant 2001; 15 (Suppl 6): 46-50